Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31562796

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2019 Nov 21
First author
Hellmann MD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2020 Feb;17(2):73-74. doi: 10.1038/s41571-019-0317-y.
    note
    Source null
    related pmid
    31907372
    relationship
    Comment in
  2. citation
    N Engl J Med. 2020 Feb 27;382(9):874. doi: 10.1056/NEJMc1916859.
    note
    Source null
    related pmid
    32101672
    relationship
    Comment in
  3. citation
    N Engl J Med. 2020 Feb 27;382(9):874-875. doi: 10.1056/NEJMc1916859.
    note
    Source null
    related pmid
    32101673
    relationship
    Comment in
  4. citation
    J Thorac Dis. 2020 Aug;12(8):4522-4526. doi: 10.21037/jtd.2020.03.77.
    note
    Source null
    related pmid
    32944367
    relationship
    Comment in
  5. citation
    Transl Cancer Res. 2020 Apr;9(4):2168-2170. doi: 10.21037/tcr.2020.03.09.
    note
    Source null
    related pmid
    35117575
    relationship
    Comment in

Authors and identifiers

  1. name
    Hellmann MD
    type
    Author
  2. name
    Paz-Ares L
    type
    Author
  3. name
    Bernabe Caro R
    type
    Author
  4. name
    Zurawski B
    type
    Author
  5. name
    Kim SW
    type
    Author
  6. name
    Carcereny Costa E
    type
    Author
  7. name
    Park K
    type
    Author
  8. name
    Alexandru A
    type
    Author
  9. name
    Lupinacci L
    type
    Author
  10. name
    de la Mora Jimenez E
    type
    Author
  11. name
    Sakai H
    type
    Author
  12. name
    Albert I
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hellmann MD
    type
    Author
  2. name
    Paz-Ares L
    type
    Author
  3. name
    Bernabe Caro R
    type
    Author
  4. name
    Zurawski B
    type
    Author
  5. name
    Kim SW
    type
    Author
  6. name
    Carcereny Costa E
    type
    Author
  7. name
    Park K
    type
    Author
  8. name
    Alexandru A
    type
    Author
  9. name
    Lupinacci L
    type
    Author
  10. name
    de la Mora Jimenez E
    type
    Author
  11. name
    Sakai H
    type
    Author
  12. name
    Albert I
    type
    Author
bibliography ids
  1. nci-bib-a2408203ad8daf74e62b4bcd
book metadata
content sha256
479331bb567f154ecfc3d6e763c0f83806bb9c20ecefa906b796f174ab2e5115
document type
citation
dois
  1. 10.1056/NEJMoa1910231
electronic publication date
display
2019 Sep 28
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31562796
immutable id
pubmed:31562796@479331bb567f154ecfc3d6e763c0f83806bb9c20ecefa906b796f174ab2e5115
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
21
name
The New England journal of medicine
nlm unique id
0255562
pages
2020-2031
volume
381
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2020 Feb;17(2):73-74. doi: 10.1038/s41571-019-0317-y.
    note
    Source null
    related pmid
    31907372
    relationship
    Comment in
  2. citation
    N Engl J Med. 2020 Feb 27;382(9):874. doi: 10.1056/NEJMc1916859.
    note
    Source null
    related pmid
    32101672
    relationship
    Comment in
  3. citation
    N Engl J Med. 2020 Feb 27;382(9):874-875. doi: 10.1056/NEJMc1916859.
    note
    Source null
    related pmid
    32101673
    relationship
    Comment in
  4. citation
    J Thorac Dis. 2020 Aug;12(8):4522-4526. doi: 10.21037/jtd.2020.03.77.
    note
    Source null
    related pmid
    32944367
    relationship
    Comment in
  5. citation
    Transl Cancer Res. 2020 Apr;9(4):2168-2170. doi: 10.21037/tcr.2020.03.09.
    note
    Source null
    related pmid
    35117575
    relationship
    Comment in
outcomes validated
false
pmid
31562796
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
e0bc63c9f2d943f6acff9c48acfbdd698bc0c69c0975fa4d6cb5e94cb43d290c
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Nov 21
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31562796/
title
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.

Preserved source evidence · Not medical advice